Your account is not claimed yet. You can sign up with ORCID to claim your account.

Patricio Soares-Da-Silva (Patrício Soares-da-Silva, Patricio Soares-da-Silva, Patrício Soares da Silva)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 16

Top Venues

Epilepsia

Clinical and experimental hypertension (New York, N.Y. : 1993)

British journal of pharmacology

The Journal of neuroscience : the official journal of the Society for Neuroscience

Faculdade de Medicina da Universidade do Porto

Faculdade de Medicina da Universidade do Porto (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Faculdade de Medicina da Universidade do Porto

Portugal

Professor :: Department of Pharmacology and Therapeutics

Education History

Faculdade de Medicina da Universidade do Porto

Portugal

PHD :: Pharmacology

Publications

Matthias J Koepp, Eugen Trinka, Yee-Haur Mah, Carla Bentes, Susanne Knake, Gian Luigi Gigli, José M Serratosa, Johan Zelano, Luís M Magalhães, Ana Pereira, Joana Moreira, Patricio Soares-Da-Silva
Antiepileptogenesis after Stroke - Trials and Tribulations: Methodological Challenges and Recruitment Results of a Phase II Study with Eslicarbazepine Acetate. Epilepsia open (2023)
Ana I Loureiro, Francisco Rocha, Ana T Santos, Nand Singh, Maria João Bonifácio, Rui Pinto, Laszlo E Kiss, Patricio Soares-Da-Silva
Absorption, metabolism and excretion of opicapone in human healthy volunteers. British journal of clinical pharmacology 88 (10) (2022)
Nuno M Pires, Bruno Igreja, Patricio Soares-Da-Silva
Antagonistic modulation of SIK1 and SIK2 isoforms in high blood pressure and cardiac hypertrophy triggered by high-salt intake. Clinical and experimental hypertension (New York, N.Y. : 1993) 43 (5) (2021)
Sarah Schmidt, Leonie Pothmann, Daniel Müller-Komorowska, Thoralf Opitz, Patricio Soares-Da-Silva, Heinz Beck
Complex effects of eslicarbazepine on inhibitory micro networks in chronic experimental epilepsy. Epilepsia 62 (2) (2021)
Luís M Magalhães, Raquel Costa, Mariana Vieira, Joana Moreira, Helena Gama, Patricio Soares-Da-Silva
Safety of Eslicarbazepine Acetate in Elderly Versus Non-Elderly Patients with Focal Seizures: From Pooled Data of Clinical Studies to 8 Years of Post-Marketing Experience. Drug safety 44 (10) (2021)
Laura Monni, Larissa Kraus, Matthias Dipper-Wawra, Patricio Soares-Da-Silva, Nikolaus Maier, Dietmar Schmitz, Martin Holtkamp, Pawel Fidzinski
In vitro and in vivo anti-epileptic efficacy of eslicarbazepine acetate in a mouse model of KCNQ2-related self-limited epilepsy. British journal of pharmacology (2021)
Heinz Reichmann, Andrew Lees, José-Francisco Rocha, Diogo Magalhães, Patricio Soares-Da-Silva, null null
Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label study. Translational neurodegeneration 9 (1) (2020)
Maria-João Bonifácio, Filipa Sousa, Cátia Aires, Ana I Loureiro, Carlos Fernandes-Lopes, Nuno M Pires, Pedro Nuno Palma, Paul Moser, Patricio Soares-Da-Silva
Preclinical pharmacological evaluation of the fatty acid amide hydrolase inhibitor BIA 10-2474. British journal of pharmacology 177 (9) (2020)
Eugen Trinka, Rodrigo Rocamora, João Chaves, Joana Moreira, Fábio Ikedo, Patricio Soares-Da-Silva, null null
Long-term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open-label extension study. Epilepsia 61 (10) (2020)
Diogo Nóbrega Catelas, Maria Paula Serrão, Patricio Soares-Da-Silva
Effects of nepicastat upon dopamine-β-hydroxylase activity and dopamine and norepinephrine levels in the rat left ventricle, kidney, and adrenal gland. Clinical and experimental hypertension (New York, N.Y. : 1993) 42 (2) (2019)
Verónica Cabreira, Patricio Soares-Da-Silva, João Massano
Contemporary Options for the Management of Motor Complications in Parkinson's Disease: Updated Clinical Review. Drugs 79 (6) (2019)
László E Kiss, Alexandre Beliaev, Humberto S Ferreira, Carla P Rosa, Maria-João Bonifácio, Ana I Loureiro, Nuno M Pires, Pedro Nuno Palma, Patricio Soares-Da-Silva
Discovery of a Potent, Long-Acting, and CNS-Active Inhibitor (BIA 10-2474) of Fatty Acid Amide Hydrolase. ChemMedChem 13 (20) (2018)
Niklas Michael Beckonert, Thoralf Opitz, Julika Pitsch, Patricio Soares-Da-Silva, Heinz Beck
Polyamine Modulation of Anticonvulsant Drug Response: A Potential Mechanism Contributing to Pharmacoresistance in Chronic Epilepsy. The Journal of neuroscience : the official journal of the Society for Neuroscience 38 (24) (2018)
Eugen Trinka, José Francisco Rocha, Patricio Soares-Da-Silva
Response: Comparing the dosages of lacosamide, eslicarbazepine acetate, and controlled-release carbamazepine in noninferiority epilepsy monotherapy trials: How much "fair" is "fair". Epilepsia 59 (4) (2018)
Dominik Holtkamp, Thoralf Opitz, Simon Hebeisen, Patricio Soares-Da-Silva, Heinz Beck
Effects of eslicarbazepine on slow inactivation processes of sodium channels in dentate gyrus granule cells. Epilepsia 59 (8) (2018)
Christian Elger, Mathias Koepp, Eugen Trinka, Vicente Villanueva, João Chaves, Elinor Ben-Menachen, Pedro A Kowacs, António Gil-Nagel, Joana Moreira, Helena Gama, José-Francisco Rocha, Patricio Soares-Da-Silva
Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Data from four double-blind placebo-controlled pivotal phase III clinical studies. CNS neuroscience & therapeutics 23 (12) (2017)

Patricio Soares-Da-Silva.css-eqlu8i{font-size:small;padding-left:4px;} (Patrício Soares-da-Silva, Patricio Soares-da-Silva, Patrício Soares da Silva)

Publication Activity (10 Years)

Top Topics

Top Venues

Patricio Soares-Da-Silva (Patrício Soares-da-Silva, Patricio Soares-da-Silva, Patrício Soares da Silva)